Wearable device to check fluid flow in brain shunts for hydrocephalus
Tests a wearable device that measures shunt flow in people with hydrocephalus.
Key facts
- Who runs it
- Rhaeos, Inc.
- Where
- Chicago, Rolling Meadows, and Tampa, United StatesSee the 4 sites
- Trial code
- Registry title
- Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
- Status
- Recruiting
- People taking part
- 130 people, planned
- Started
- 17 Nov 2023
- Planned end
- Dec 2025
- Type of study
- Interventional
- Treatments tested
- Thermal Anisotropy Measurement Device
- Record updated
- 15 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with hydrocephalus who already have a shunt, a thin tube that drains brain fluid. They will wear a skin device that measures flow in the shunt.
- Age
- 5 Years to 80 Years
- Sex
- All sexes can join
- Disease stage
- At least one existing ventricular CSF shunt, working or not working. This includes shunts set to "virtual off" and tied-off, abandoned or broken tubes. The shunt must cross the collarbone under intact skin.
- Earlier treatment
- Must already have an implanted shunt.
Main reasons for not taking part
- An open wound or swelling over any part of the shunt
- Past skin reactions to adhesives (sticky tape)
- Unable to take reliable measurements or place the device at home without help
- Device use would interfere with standard care or emergency surgery
- Taking part in another study that may affect the data
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- At least one existing ventricular CSF shunt (functional or non-functional, including "virtual off" and ligated, orphaned, abandoned, tied-off, or fractured distal catheters)
- Region(s) of intact skin overlying at least one unambiguously identifiable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device
- Available for remote and in-person follow-up during the 30-day measurement period (for subjects using the study device at home)
- Subject is expected to remain in an inpatient setting for sufficient time to complete all required study device measurements (for subjects using the device in an inpatient hospital setting)
- Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
- Subject or caregiver is able to clearly communicate and document information and shunt symptoms in English
- Verbal assent by minors 12 years of age and older who are able to understand the study and communicate their decision
- Patient is at least 5 years old but not more than 80 years old
Who cannot take part
- Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
- Patient-reported history of adverse skin reactions to adhesives
- Presence of an interfering open wound or edema over any portion of the shunt
- Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable
- Investigator judges that the subject is unlikely to successfully take reliable measurements at home (for subjects using the study device at home)
- Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance
- Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 80 years old?
Where in United States
- MATTERChicago, United StatesContact: Anna SomeraTaking people
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: Anna SomeraNo longer taking part
- Northwest Special Recreation AssociationRolling Meadows, United StatesContact: Anna SomeraTaking people
- Tampa Marriott Water StreetTampa, United StatesContact: Anna SomeraTaking people
About the trial
What the trial wants to find out
This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to acquire longitudinal data.
The group in the trial
- Feasibility Assessment CohortTreatment being tested
Non-invasive device data acquisition; study is not interventional
Treatment: Thermal Anisotropy Measurement Device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
- Plain-language title
- Wearable device to check fluid flow in brain shunts for hydrocephalusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06086561, who can take part
- Record updated
- 15 May 2025